Thursday, February 2, 2017

CAC 40: a note of fragility in the pre-open. – EasyBourse.com

Pr�-opening

CAC 40: a note of fragilit� in pr�opening.

published on 02/02/2017

(CercleFinance.com) – The Paris Bourse should start � lower Thursday morning apr�s have sign� the day before a rebound of the order of 1% cons�executive � four s�ances drop affil�e. Around 8: 15, the future contract on the CAC 40 index – delivery f�February – declined, and 16 points � 4777,5 points, portending an opening in the red.

‘ind�decision dominates and the volatilit� should take a hit’, pr�just this morning a trader.Yesterday, the march� parisian had made mine clear his ‘faux pas’ in the 4800 points of the eve by raising the bar up to 4824 points before cl�recapture � 4795 points, which makes the sc�nario of a rebound is uncertain apr�s sp�specialists.The 1% increase in sign�e yesterday does not invalidate the sc�nario downward in the direction of the ‘gap’ of 4640 points of the 6 d�December last, consider in particular the technical analysts.

And if Wall Street has done� in the green yesterday evening, it did �t� that for a few centi�my points gr�this � the flamb�e of the title Apple has made the diff�conference with a historical gain of 6% with no less than 111 million shares �chang�s. r�action from Wall Street to the communiqu� of the Fed has �t� much less spectacular. It must be said that, in addition to the confirmation of a status quo on rates (anticip� � of 99.99%), the institution has not given� no track regarding the date and the en�quence of the next few ‘turns of the screw’.

The highlight of the day�e yesterday has �t� the publication of r�results of Facebook, not surprisingly sup�laughing to the expectations.The s�ance promises to be moreover the particular�particularly rich in publications of r�results in Europe, with the accounts of AstraZeneca, Shell, Nokia, Deutsche Bank, ING, Daimler, Infineon and Vodafone.Copyright (c) 2017 CercleFinance.com. All rights r�serv�s.

CercleFinance

LikeTweet

No comments:

Post a Comment